O-2113

From WikiMD's Food, Medicine & Wellness Encyclopedia

O-2113_Structure.svg

O-2113 is a synthetic cannabinoid that has been studied for its potential therapeutic effects. It is a member of the cannabinoid class of compounds, which interact with the endocannabinoid system in the body.

Chemical Structure and Properties[edit | edit source]

O-2113 is chemically related to other cannabinoids, such as THC (tetrahydrocannabinol) and CBD (cannabidiol). The specific chemical structure of O-2113 includes a core cannabinoid structure with various functional groups that influence its interaction with cannabinoid receptors.

Pharmacology[edit | edit source]

O-2113 primarily interacts with the CB1 and CB2 receptors in the endocannabinoid system. These receptors are part of the G protein-coupled receptor family and are involved in various physiological processes, including pain sensation, mood regulation, and immune response.

CB1 Receptor[edit | edit source]

The CB1 receptor is predominantly found in the central nervous system, including the brain and spinal cord. Activation of CB1 receptors by cannabinoids like O-2113 can result in psychoactive effects, although the specific effects of O-2113 are still under investigation.

CB2 Receptor[edit | edit source]

The CB2 receptor is primarily located in the immune system and peripheral tissues. Activation of CB2 receptors is associated with anti-inflammatory and immunomodulatory effects. O-2113's interaction with CB2 receptors suggests potential therapeutic applications in conditions involving inflammation and immune response.

Therapeutic Potential[edit | edit source]

Research on O-2113 has explored its potential in various medical conditions. Some studies suggest that it may have analgesic (pain-relieving) properties, making it a candidate for the treatment of chronic pain conditions. Additionally, its interaction with the CB2 receptor indicates potential benefits in inflammatory diseases and immune disorders.

Safety and Side Effects[edit | edit source]

As with other synthetic cannabinoids, the safety profile of O-2113 is an important consideration. Potential side effects may include dizziness, dry mouth, and changes in appetite. Long-term safety data is limited, and further research is needed to fully understand the risks associated with its use.

Legal Status[edit | edit source]

The legal status of O-2113 varies by jurisdiction. In some regions, synthetic cannabinoids are regulated under controlled substances laws, while in others, they may be available for research purposes only.

See Also[edit | edit source]

References[edit | edit source]


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD